Skip to main content
. 2022 Apr 13;12:858740. doi: 10.3389/fonc.2022.858740

Table 1.

Patient characteristics.

Characteristic N
Median age 66 years (51-85)
Risk Group
Low risk 3
Intermediate risk 7
High risk 12
Median time interval between RT courses 72 months (12-1460)
Median PSA pre-reSBRT 1.7 ng/ml (0.34 - 8.58 ng/ml)
Site of recurrence
Prostate bed 10/22
Prostate 12/22
Re-SBRT dose 30 Gy/5 fractions
Concurrent ADT 4/22